<DOC>
	<DOCNO>NCT01172145</DOCNO>
	<brief_summary>This study examine effect modafinil apathetic symptomatology , performance activity daily live ( ADLs ) caregiver burden individual Alzheimer 's disease ( AD ) .</brief_summary>
	<brief_title>Treatment Apathy Alzheimer 's Disease With Modafinil</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<criteria>diagnosis mild moderate stage Probable Alzheimer 's disease stable dose cholinesterase inhibitor medication least 30 day clinically elevated level apathy measure Frontal Systems Behavior Scale diagnosis Major Depression focal brain lesion neuroimaging history significant substance abuse history significant head trauma loss consciousness &gt; 10 minute</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>apathy</keyword>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>activity daily live performance</keyword>
	<keyword>caregiver burden</keyword>
</DOC>